American Oncology Network, Inc. (AONC)
OTCMKTS · Delayed Price · Currency is USD
4.815
+0.115 (2.45%)
Dec 26, 2024, 3:00 PM EST

American Oncology Network Statistics

Total Valuation

American Oncology Network has a market cap or net worth of 130.47 million. The enterprise value is 416.34 million.

Market Cap 130.47M
Enterprise Value 416.34M

Important Dates

The next estimated earnings date is Friday, March 28, 2025.

Earnings Date Mar 28, 2025
Ex-Dividend Date n/a

Share Statistics

American Oncology Network has 27.10 million shares outstanding. The number of shares has increased by 93.85% in one year.

Current Share Class n/a
Shares Outstanding 27.10M
Shares Change (YoY) +93.85%
Shares Change (QoQ) -64.24%
Owned by Insiders (%) 33.05%
Owned by Institutions (%) 0.09%
Float 18.14M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.03
PB Ratio n/a
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -28.58
EV / Sales 0.26
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -9.01

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 2.72.

Current Ratio 1.36
Quick Ratio 1.05
Debt / Equity 2.72
Debt / EBITDA n/a
Debt / FCF -3.19
Interest Coverage -5.27

Financial Efficiency

Return on equity (ROE) is -70.28% and return on invested capital (ROIC) is -11.38%.

Return on Equity (ROE) -70.28%
Return on Assets (ROA) -6.16%
Return on Capital (ROIC) -11.38%
Revenue Per Employee 1.04M
Profits Per Employee -9,551
Employee Count 1,525
Asset Turnover 4.04
Inventory Turnover 34.47

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -20.62% in the last 52 weeks. The beta is 0.34, so American Oncology Network's price volatility has been lower than the market average.

Beta (5Y) 0.34
52-Week Price Change -20.62%
50-Day Moving Average 3.91
200-Day Moving Average 3.48
Relative Strength Index (RSI) 61.66
Average Volume (20 Days) 4,061

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) 2.03

Income Statement

In the last 12 months, American Oncology Network had revenue of 1.59 billion and -14.56 million in losses. Loss per share was -4.05.

Revenue 1.59B
Gross Profit 91.45M
Operating Income -38.90M
Pretax Income -49.08M
Net Income -14.56M
EBITDA -29.36M
EBIT -38.90M
Loss Per Share -4.05
Full Income Statement

Balance Sheet

The company has 19.43 million in cash and 147.39 million in debt, giving a net cash position of -127.95 million or -4.72 per share.

Cash & Cash Equivalents 19.43M
Total Debt 147.39M
Net Cash -127.95M
Net Cash Per Share -4.72
Equity (Book Value) 54.09M
Book Value Per Share -7.78
Working Capital 71.37M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -28.83 million and capital expenditures -17.38 million, giving a free cash flow of -46.21 million.

Operating Cash Flow -28.83M
Capital Expenditures -17.38M
Free Cash Flow -46.21M
FCF Per Share -1.71
Full Cash Flow Statement

Margins

Gross margin is 5.74%, with operating and profit margins of -2.44% and -0.57%.

Gross Margin 5.74%
Operating Margin -2.44%
Pretax Margin -3.08%
Profit Margin -0.57%
EBITDA Margin -1.84%
EBIT Margin -2.44%
FCF Margin n/a

Dividends & Yields

American Oncology Network does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -93.85%
Shareholder Yield -93.85%
Earnings Yield -84.14%
FCF Yield -35.42%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

American Oncology Network has an Altman Z-Score of 3.64.

Altman Z-Score 3.64
Piotroski F-Score n/a